Robert Shore, PhD

Robert is an accomplished healthcare professional with a strong background in business development, corporate finance and scientific research. He holds an MBA from the University of Cambridge and a PhD in Medicine from the University of St Andrews.

​​

Before founding Shorefox Partners, Robert was a Senior Director at AstraZeneca, where he integrated financial insights into oncology strategies, influencing key business decisions. Previously, Robert was a Portfolio Manager at a London family office, where he grew assets under management to over $50M with a focus on biopharma public equities.

​​

Other previous experience includes conducting vaccine research as a postdoctoral fellow at Harvard Medical School. Following this role, he worked as a Biopharmaceutical Equity Research Analyst at a prominent Wall Street firm, where he performed comprehensive analyses of biopharmaceutical technologies.

​

Robert is dedicated to healthcare advocacy and was previously a trustee for Dementia Prevention UK.